KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer

NCT05483491 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Breast Cancer
Cervical Cancer
Lung Cancer

Interventions

BIOLOGICAL: KK-LC-1 TCR-T cells
DRUG: Aldesleukin

Sponsor

Christian Hinrichs

Collaborators

[object Object]
[object Object]